Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 10, 2017 - Issue
Submit an article Journal homepage
608
Views
70
CrossRef citations to date
0
Altmetric
Original Research

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes

Mirko V Sikirica1 Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USACorrespondence[email protected]
,
Alan A Martin2 Value Evidence and Outcomes, GlaxoSmithKline, London, UK
,
Robert Wood3 Diabetes, Adelphi Real World, Bollington, Cheshire, UK
,
Andrea Leith3 Diabetes, Adelphi Real World, Bollington, Cheshire, UK
,
James Piercy3 Diabetes, Adelphi Real World, Bollington, Cheshire, UK
&
Victoria Higgins3 Diabetes, Adelphi Real World, Bollington, Cheshire, UK
Pages 403-412 | Published online: 29 Sep 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.